Inactive Instrument
Quotes ValiRx Plc London S.E.
Stocks
GB00B23N9136
Biotechnology & Medical Research
|
End-of-day quote
London S.E.
|
||
| - GBX | - |
|
| 08-10 | ValiRx subsidiary Cytolytix nears "significant" European patent win | AN |
| 08-10 | ValiRx Unit Receives Intention to Grant European Patent for Anti-Cancer Peptide | MT |
Stock exchange
London S.E.- p
-
0
p
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| VAL | 0.1550GBX | 0.00% | 252K p | ||
Deutsche Boerse AG
| EAJF | 0.000500EUR | 0.00% | 0 € | |
|
Börse Stuttgart
| EAJF | 0.001500EUR | 0.00% | 0 € |
Basic data
Market Cap (GBX)
2,046,466
Market Cap (USD)
2,774,794
Net sales (GBP)
0
Free-Float
91.05 %
Free-Float capitalization (GBX)
1,863,217
Free-Float capitalization (USD)
2,526,327
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 2.77M | |
| -1.59% | -3.35% | +52.37% | +93.70% | 69.54B | |
| -1.34% | -0.75% | +48.21% | +91.86% | 64.97B | |
| +0.30% | -0.69% | +52.56% | +10.23% | 26.51B | |
| -2.35% | -5.75% | -12.90% | +448.54% | 25.89B | |
| -8.37% | -12.43% | +2.08% | -16.71% | 25.64B | |
| -0.96% | +10.36% | +283.06% | +436.50% | 20.22B | |
| -0.51% | +0.23% | +35.77% | -18.70% | 19.98B | |
| -1.91% | -4.37% | +13.28% | +535.19% | 15.69B | |
| -1.47% | +0.68% | +45.51% | +143.08% | 13.49B | |
| Average | -2.02% | -1.93% | +57.77% | +191.52% | 28.19B | |
| Weighted average by Cap. | -1.93% | -1.50% | +53.73% | +151.51% |
Historical Quotes: ValiRx Plc
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- VAL Stock
- Stock
- Quotes ValiRx Plc
Select your edition
All financial news and data tailored to specific country editions
